about
Intracellular anti-E7 human antibodies in single-chain format inhibit proliferation of HPV16-positive cervical carcinoma cells.Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cellsMucosal and cutaneous human papillomaviruses detected in raw sewagesSerum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development.Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models.Antibodies in single-chain format against tumour-associated antigens: present and future applications.Frequent and abundant Merkel cell polyomavirus detection in urban wastewaters in Italy.A large spectrum of alpha and beta papillomaviruses are detected in human stool samples.Human antibody response to Toscana virus glycoproteins expressed by recombinant baculovirus.In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16.Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered ExosomesUp-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancerThe Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected CellsComprehensive analysis of β- and γ-human papillomaviruses in actinic keratosis and apparently healthy skin of elderly patients
P50
Q31158683-D4DBCC8D-87E9-4EAD-A954-BF85BE93A17AQ33271188-13DD3F6D-E807-46A8-8A41-3621269F79E2Q33795204-DB409445-F6EE-4BF3-BF52-39E289A41912Q34558258-FEEF0EAB-69CF-4DA0-A085-EE3CDC8B2647Q35165681-497D03A2-E888-455F-B76F-7AC269D04FD8Q35605933-C5437F2F-E103-4428-99F4-FABEED2FAA8BQ35769502-AC4EFE29-490A-45A6-946E-988403D90FC3Q35774362-6FDE92CE-7C2F-462C-8A7C-FED2FB033036Q37085816-CD760EBC-AFA1-49FD-8F5E-AA33840F25E9Q37719573-B3CFB6F0-409D-4C63-B818-A171C67E12ABQ40229931-02420995-27CD-44A1-AE3D-868C9DD65B78Q40234967-98BF5240-5D43-4AA1-81BE-9BE927082FC3Q40573084-95A6C1C4-4412-44BF-A3A4-04285B6D6C21Q42240819-978948FC-70BF-4CBC-BCDC-E3035850534DQ55008093-ADE90F45-EDA8-4588-BD17-1FEC9F558967Q64244575-6E7D86D7-2D31-4DA3-A2C6-FCAA7D91F09CQ79349338-F593F786-393E-45D8-98F1-B34E1E74F031Q91737281-D27BFFC4-CBD5-46B0-8FCB-435D9DA2B096Q92065679-F3901942-F725-4D0E-B2D5-F3DE2216B21F
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5091-9272
@en
name
Luisa Accardi
@ast
Luisa Accardi
@en
Luisa Accardi
@es
Luisa Accardi
@nl
type
label
Luisa Accardi
@ast
Luisa Accardi
@en
Luisa Accardi
@es
Luisa Accardi
@nl
prefLabel
Luisa Accardi
@ast
Luisa Accardi
@en
Luisa Accardi
@es
Luisa Accardi
@nl
P106
P1153
7007148406
P21
P31
P496
0000-0002-5091-9272